Praxis Precision Medicines, Inc.
For the period ended Mar 31, 2026. Filed May 7, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 7, 2026
PRAX$337.59+1.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Comprehensive Loss for
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
(Amounts in thousands)
| Three Months EndedMarch 31, | ||
|---|---|---|
| 2026 | 2025 | |
| Net loss | $(92,561) | $(69,296) |
| Change in unrealized (loss) gain on marketable securities, net of tax | (2,157) | 5 |
| Comprehensive loss | $(94,718) | $(69,291) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.